Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Framingham Risk Stratification of Middle-Aged Migraineurs.

Bank G, Kapus K, Meszaros J, Mak K, Pohl M, Pusch G, Fejes E, Tibold A, Feher G.

Behav Neurol. 2020 Feb 7;2020:7351214. doi: 10.1155/2020/7351214. eCollection 2020.

2.

Characteristics of Patients Referred To A Specialized Headache Clinic.

Fejes E, Feher G, Gurdan Z, Gombos K, Koltai K, Pusch G, Tibold A.

Sci Rep. 2020 Jan 24;10(1):1146. doi: 10.1038/s41598-020-58234-w.

3.

[Chronic orofacial pain].

Fehér G, Nemeskéri Z, Pusch G, Zádori I, Bank G, Gurdán Z, Mészáros J, Mák K, Tibold A, Komoly S.

Orv Hetil. 2019 Jul;160(27):1047-1056. doi: 10.1556/650.2019.31432. Review. Hungarian.

PMID:
31264469
4.

Early seizures after ischemic stroke: focus on thrombolysis.

Feher G, Gurdan Z, Gombos K, Koltai K, Pusch G, Tibold A, Szapary L.

CNS Spectr. 2020 Feb;25(1):101-113. doi: 10.1017/S1092852919000804.

PMID:
30915936
5.

Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.

Koltai K, Kesmarky G, Feher G, Tibold A, Toth K.

Int J Mol Sci. 2017 Aug 18;18(8). pii: E1803. doi: 10.3390/ijms18081803. Review.

6.

Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke.

Pusch G, Debrabant B, Molnar T, Feher G, Papp V, Banati M, Kovacs N, Szapary L, Illes Z.

J Stroke Cerebrovasc Dis. 2015 Aug;24(8):1938-47. doi: 10.1016/j.jstrokecerebrovasdis.2015.05.005. Epub 2015 Jun 4.

PMID:
26051664
7.

Do we have to anticoagulate patients with cerebral venous thrombosis?

Feher G, Illes Z, Hargroves D, Komoly S.

Int Angiol. 2016 Aug;35(4):369-73. Epub 2015 May 28. Review.

PMID:
26017760
8.

Novel oral anticoagulants in the treatment of cerebral venous thrombosis.

Feher G, Illes Z, Komoly S, Hargroves D.

Int Angiol. 2016 Aug;35(4):365-8. Epub 2015 May 21. Review.

PMID:
25994451
9.

[Role of antihypertensive drugs in the treatment of migraine].

Fehér G, Pusch G.

Orv Hetil. 2015 Feb 1;156(5):179-85. doi: 10.1556/OH.2015.30056. Review. Hungarian.

PMID:
25618859
10.

[Clopidogrel resistance in cerebrovascular disease -- results of one-year follow-up].

Szapáry L, Koltai K, Tibold A, Fehér A, Harang G, Pusch G, Fehér G.

Orv Hetil. 2015 Jan 11;156(2):53-9. doi: 10.1556/OH.2015.30057. Hungarian.

PMID:
25563682
11.

[Unfavorable outcome of aggressive lowering of high blood pressure. Case report].

Kuperczkó D, Csécsei P, Komáromy H, Szapáry L, Fehér G.

Orv Hetil. 2014 Oct 19;155(42):1685-9. doi: 10.1556/OH.2014.30011. Hungarian.

PMID:
25305726
12.

The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.

Molnar T, Pusch G, Papp V, Feher G, Szapary L, Biri B, Nagy L, Keki S, Illes Z.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2206-2214. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.002. Epub 2014 Jul 10.

PMID:
25018114
13.

Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients.

Koltai K, Papp J, Kenyeres P, Feher G, Tibold A, Alexy T, Marton Z, Kesmarky G, Toth K.

Biorheology. 2014;51(2-3):197-206. doi: 10.3233/BIR-140661.

PMID:
24898335
14.

Diabetic neuropathies: diagnosis and management.

Deli G, Bosnyak E, Pusch G, Komoly S, Feher G.

Neuroendocrinology. 2013;98(4):267-80. doi: 10.1159/000358728. Epub 2014 Jan 22. Review.

15.

[Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].

Szapary L, Fehér G, Bosnyák E, Deli G, Csécsei P.

Ideggyogy Sz. 2013 May 30;66(5-6):165-74. Review. Hungarian.

PMID:
23909016
16.

[Vinpocetin in neurological diseases].

Szapáry L, Késmárky G, Tóth K, Misnyovszky M, Tóth T, Balogh A, Nagy K, Németh GY, Fehér G.

Ideggyogy Sz. 2012 Nov 30;65(11-12):387-93. Review. Hungarian. Erratum in: Ideggyogy Sz. 2013 Jan 30;66(1-2):13. Németh, György [corrected to Németh, György Y].

PMID:
23289173
17.

[Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].

Szapáry L, Fehér G.

Orv Hetil. 2012 Jun 3;153(22):857-60. doi: 10.1556/OH.2012.29390. Hungarian.

PMID:
22641260
18.

Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.

Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E.

Clin Hemorheol Microcirc. 2012;50(3):179-87. doi: 10.3233/CH-2011-1424.

PMID:
22240353
19.

Aspirin resistance in cerebrovascular patients.

Feher A, Pusch G, Harang G, Gasztonyi B, Papp E, Werling D, Menyhart M, Komaromy H, Szapary L, Feher G.

Int J Cardiol. 2011 Oct 6;152(1):111-2. doi: 10.1016/j.ijcard.2011.07.028. Epub 2011 Jul 27. No abstract available.

PMID:
21794938
20.

Thrombosis preventive potential of chicory coffee consumption: a clinical study.

Schumacher E, Vigh E, Molnár V, Kenyeres P, Fehér G, Késmárky G, Tóth K, Garai J.

Phytother Res. 2011 May;25(5):744-8. doi: 10.1002/ptr.3481. Epub 2011 Mar 21.

PMID:
21425378

Supplemental Content

Loading ...
Support Center